Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]

Javier Zarranz-Ventura,1 Joshua O Mali2 1Institut Clínic d’Oftalmología (ICOF), Hospital Clinic, Barcelona, Spain; 2The Eye Associates, Sarasota, FL, USACorrespondence: Javier Zarranz-VenturaInstitut Clínic d’Oftalmología (ICOF), Hospit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zarranz-Ventura J, Mali JO
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/cb30bb0aa04343109604b98c82bcae47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cb30bb0aa04343109604b98c82bcae47
record_format dspace
spelling oai:doaj.org-article:cb30bb0aa04343109604b98c82bcae472021-12-02T16:03:02ZComment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]1177-5483https://doaj.org/article/cb30bb0aa04343109604b98c82bcae472020-11-01T00:00:00Zhttps://www.dovepress.com/comment-on-rsquoeffectiveness-of-190-mug-fluocinolone-acetonide-versus-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Javier Zarranz-Ventura,1 Joshua O Mali2 1Institut Clínic d’Oftalmología (ICOF), Hospital Clinic, Barcelona, Spain; 2The Eye Associates, Sarasota, FL, USACorrespondence: Javier Zarranz-VenturaInstitut Clínic d’Oftalmología (ICOF), Hospital Clinic, Barcelona, SpainTel +34 932 279 391Email jzarranz@hotmail.com With interest, we read the letter to the Editor regarding the Effectiveness of 190 μg fluocinolone acetonide versus 700 μg dexamethasone intravitreal implants in diabetic macular edema using the area-under-the-curve method: The CONSTANT analysis by Stewart and Taylor published in Clinical Ophthalmology. The key concerns raised by the authors relate to the design deficiencies of the MEAD studies1 and highlight two specific issues – the six month dosing of the dexamethasone implant and the potentially delayed removal of cataracts.   View the original paper by Zarranz-Ventura and Mali   This is in response to the Letter to the Editor      Zarranz-Ventura JMali JODove Medical Pressarticlearea under the curvebest-corrected visual acuitydiabetic macular edemacorticosteroidfluocinolone acetonide implantdexamethasone implantOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 3831-3832 (2020)
institution DOAJ
collection DOAJ
language EN
topic area under the curve
best-corrected visual acuity
diabetic macular edema
corticosteroid
fluocinolone acetonide implant
dexamethasone implant
Ophthalmology
RE1-994
spellingShingle area under the curve
best-corrected visual acuity
diabetic macular edema
corticosteroid
fluocinolone acetonide implant
dexamethasone implant
Ophthalmology
RE1-994
Zarranz-Ventura J
Mali JO
Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
description Javier Zarranz-Ventura,1 Joshua O Mali2 1Institut Clínic d’Oftalmología (ICOF), Hospital Clinic, Barcelona, Spain; 2The Eye Associates, Sarasota, FL, USACorrespondence: Javier Zarranz-VenturaInstitut Clínic d’Oftalmología (ICOF), Hospital Clinic, Barcelona, SpainTel +34 932 279 391Email jzarranz@hotmail.com With interest, we read the letter to the Editor regarding the Effectiveness of 190 μg fluocinolone acetonide versus 700 μg dexamethasone intravitreal implants in diabetic macular edema using the area-under-the-curve method: The CONSTANT analysis by Stewart and Taylor published in Clinical Ophthalmology. The key concerns raised by the authors relate to the design deficiencies of the MEAD studies1 and highlight two specific issues – the six month dosing of the dexamethasone implant and the potentially delayed removal of cataracts.   View the original paper by Zarranz-Ventura and Mali   This is in response to the Letter to the Editor      
format article
author Zarranz-Ventura J
Mali JO
author_facet Zarranz-Ventura J
Mali JO
author_sort Zarranz-Ventura J
title Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
title_short Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
title_full Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
title_fullStr Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
title_full_unstemmed Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
title_sort comment on ’effectiveness of 190 μg fluocinolone acetonide versus 700 μg dexamethasone intravitreal implants in diabetic macular edema using the area-under-the-curve method: the constant analysis’ [response to letter]
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/cb30bb0aa04343109604b98c82bcae47
work_keys_str_mv AT zarranzventuraj commentonrsquoeffectivenessof190mugfluocinoloneacetonideversus700mugdexamethasoneintravitrealimplantsindiabeticmacularedemausingtheareaunderthecurvemethodtheconstantanalysisrsquoresponsetoletter
AT malijo commentonrsquoeffectivenessof190mugfluocinoloneacetonideversus700mugdexamethasoneintravitrealimplantsindiabeticmacularedemausingtheareaunderthecurvemethodtheconstantanalysisrsquoresponsetoletter
_version_ 1718385299168428032